LOW-DOSE VERSUS HIGH-DOSE TOCILIZUMAB IN COVID-19 PATIENTS WITH HYPOXIC RESPIRATORY FAILURE

被引：0
|
作者：
Wang, Wai Man [1 ]
Chen, Xian Jie [2 ]
Chung, Juri [2 ]
Li, Wai Kin
Islam, Shahidul [3 ]
Altshuler, Diana [4 ]
Spiegler, Peter [2 ]
Brosnahan, Shari [4 ]
机构：
[1] NYU Langone Hosp Long Isl, Mineola, NY USA
[2] NYU Langone Hosp, Long Isl City, NY USA
[3] NYU Long Isl Sch Med, Mineola, NY USA
[4] NYU Langone Hlth, New York, NY USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1108
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [1] Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
    Brosnahan, Shari B.
    Chen, Xian Jie Cindy
    Chung, Juri
    Altshuler, Diana
    Islam, Shahidul
    Thomas, Sarun, V
    Winner, Megan D.
    Greco, Allison A.
    Divers, Jasmin
    Spiegler, Peter
    Sterman, Daniel H.
    Parnia, Sam
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (03) : 237 - 244
  • [2] Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
    Chen, Xian Jie Cindy
    Altshuler, Diana
    Spiegler, Peter
    Brosnahan, Shari B.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (04) : 507 - 508
  • [3] Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
    Bissell, Brittany D.
    Mefford, Breanne
    Donaldson, J. Chris
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (04) : 505 - 506
  • [4] Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure
    Chung, Juri
    Brosnahan, Shari B.
    Islam, Shahidul
    Altshuler, Diana
    Spiegler, Peter
    Li, Wai Kin
    Wang, Wai Man
    Chen, Xian Jie Cindy
    JOURNAL OF CRITICAL CARE, 2023, 76
  • [5] The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome
    Katz, Alyson
    Altshuler, Diana
    Papadopoulos, John
    Amoroso, Nancy
    Goldenberg, Ronald
    Tarras, Elizabeth
    Krolikowski, Kelsey
    Hagedorn, Jacklyn
    Fridman, David
    Chen, Xian Jie Cindy
    Iturrate, Eduardo
    Brosnahan, Shari B.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (01) : 5 - 15
  • [6] Vigilance in selection of low-dose versus high-dose steroids in COVID-19
    Thangaraju, Pugazhenthan
    Kumar, B. Aravind
    Venkatesan, Sajitha
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 109 : 54 - 55
  • [7] High-dose versus low-dose losartan in patients with heart failure
    Erol, Adnan
    LANCET, 2010, 375 (9720): : 1079 - 1079
  • [8] High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis
    Tan, Rachel Si Jing
    Ng, Ka Ting
    Xin, Chua Ee
    Atan, Rafidah
    Yunos, Norazim Mohd
    Hasan, M. Shahnaz
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (09) : 3576 - 3586
  • [9] Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial
    Wu, Huimin
    Daouk, Salim
    Kebbe, Jad
    Chaudry, Fawad
    Harper, Jarrod
    Brown, Brent
    PLOS ONE, 2022, 17 (10):
  • [10] Randomized, prospective study of low-dose versus high-dose inhaled nitric oxide in the neonate with hypoxic respiratory failure
    Finer, NN
    Sun, JW
    Rich, W
    Knodel, E
    Barrington, KJ
    PEDIATRICS, 2001, 108 (04) : 949 - 955
12345